New Deal
Angela Rodell
CEO at ALASKA PERMANENT FUND CORPORATION
Investor
Deal Bio
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Expertise (6)
Key Relationships
Announcement Date
Deal Value
Sana Biotechnology
Arch Venture Partners
£560m
30 dealmakers
Indigo
Alaska Permanent Fund Corporation
£412m
8 dealmakers
Tessera Therapeutics
Altitude Life Science Ventures
£170m
19 dealmakers
Repertoire Immune Medicines
Flagship Pioneering
£137m
17 dealmakers
Generate Biomedicines
£274m
11 dealmakers
Mirae Asset Financial Group
£218m